| Phosphoproteomics |
Phosphorylation of CORTACTIN
| C18 (+) Inhibitors | Alignment / Methods |
| IMAC (+) Inhibitors | Alignment / Methods |
| IMAC (+) Inhibitors (dup) | Alignment / Methods |
| C18 (+) Inhibitors LQ | Alignment / Methods |
| C18 (+) Inhibitors LFT | Alignment / Methods |
| C18 (+) Inhibitors LysC | Alignment / Methods |
| IMAC (+) Inhibitors LysC | Alignment / Methods |
| C18 (+) Inhibitors (vanadate) | Alignment / Methods |
| IMAC (+) Inhibitors (vanadate) | Alignment / Methods |
| C18 (-) Inhibitors + ThichA deacetylase inhibitor | Alignment / Methods |
| IMAC (-) Inhibitors + ThichA deacetylase inhibitor | Alignment / Methods |
| Site | Position | Peptide | ||
|---|---|---|---|---|
| (+) Inhib | (-) Inhib | |||
| 11S | 3 - 22 | KASAGHAVSITQDDGGADDW | ++ | |
| 11S | 3 - 39 | KASAGHAVSITQDDGGADDWETDPDFVNDVSEKEQRW | ++++ | # |
| 11S | 4 - 17 | ASAGHAVSITQDDG | ||
| 11S | 4 - 35 | ASAGHAVSITQDDGGADDWETDPDFVNDVSEK | ++++ | |
| 11S-13T | 3 - 39 | KASAGHAV[SIT]QDDGGADDWETDPDFVNDVSEKEQRW | +++ | |
| 13T | 4 - 17 | ASAGHAVSITQDDG | ||
| 13T | 4 - 35 | ASAGHAVSITQDDGGADDWETDPDFVNDVSEK | ++ | |
| 13T | 4 - 42 | ASAGHAVSITQDDGGADDWETDPDFVNDVSEKEQRWGAK | ++++ | |
| 24T | 4 - 35 | ASAGHAVSITQDDGGADDWETDPDFVNDVSEK | ||
| 135S | 126 - 139 | GVQMDRVDQSAVGF | # | |
| 150S | 140 - 154 | EYQGKTEKHASQKDY | # | |
| 172S | 163 - 176 | GVQADRVDKSAVGF | ++ | # |
| 182T | 177 - 191 | DYQGKTEKHESQKDY | # | |
| 209S | 200 - 213 | GIDKDKVDKSAVGF | # | |
| 282S | 274 - 287 | GVQSERQDSSAVGF | # | |
| 283S | 273 - 287 | FGVQSERQDSSAVGF | ||
| 283S | 274 - 287 | GVQSERQDSSAVGF | ++++ | |
| 322S | 311 - 334 | GVQKDRMDKNASTFEEVVQVPSAY | ++++ | |
| 322S-323T | 320 - 336 | NA[ST]FEEVVQVPSAYQK | + | |
| 345S | 335 - 354 | QKTVPIEAVTSKTSNIRANF | # | |
| 348S | 335 - 354 | QKTVPIEAVTSKTSNIRANF | # | |
| 407S / 417S-421Y | 399 - 427 | KQTPPASPSPQPIEDRPP[SSPIY]EDAAPF | ++ | |
| 417S-418S | 413 - 427 | DRPP[SS]PIYEDAAPF | ||
| 417S-418S | 414 - 427 | RPP[SS]PIYEDAAPF | ||
| 417S-421Y | 413 - 427 | DRPP[SSPIY]EDAAPF | ||
| 417S-421Y | 414 - 427 | RPP[SSPIY]EDAAPF | ||
| 454S | 428 - 460 | KAEPSYRGSEPEPEYSIEAAGIPEAGSQQGLTY | ++ | |
| 468T | 467 - 482 | ETTEAPGHYQAEDDTY | # | |
| 475Y | 467 - 482 | ETTEAPGHYQAEDDTY | # | |
*Peptides detected only by
enrichment with
immobilized metal-affinity chromatography (IMAC).
# Peptides which do not require enrichment by IMAC for detection.